Clinical Trial Update: Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a multi-center Phase 1/2 study of belantamab mafodotin in combination with pomalidomide and dexamethasone for relapsed and/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Blenrep (belantamab mafodotin)
• DEXAMETHASONE (Dexamethasone)
• Pomalyst (pomalidomide)

Snippet

Sponsor: Canadian Myeloma Research Group | Conditions: Relapsed and/or Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING